Testing for non-inferior mortality: a systematic review of non-inferiority margin sizes and trial characteristics
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Objective: To describe the size and variability of non-inferiority margins used in non-inferiority trials of medications with primary outcomes involving mortality, and to examine the association between trial characteristics and non-inferiority margin size. Design: Systematic review. Data sources: Medline, Medline In Process, Medline Epub Ahead of Print and Embase Classic+Embase databases from January 1989 to December 2019. Eligibility criteria: Prospective non-inferiority randomised controlled trials comparing pharmacological therapies, with primary analyses for non-inferiority and primary outcomes involving mortality alone or as part of a composite outcome. Trials had to prespecify non-inferiority margins as absolute risk differences or relative to risks of outcome and provide a baseline risk of primary outcome in the control intervention. Results: 3992 records were screened, 195 articles were selected for full text review and 111 articles were included for analyses. 82% of trials were conducted in thrombosis, infectious diseases or oncology. Mortality was the sole primary outcome in 23 (21%) trials, and part of a composite primary outcome in 88 (79%) trials. The overall median non-inferiority margin was an absolute risk difference of 9% (IQR 4.2%–10%). When non-inferiority margins were expressed relative to the baseline risk of primary outcome in control groups, the median relative non-inferiority margin was 1.5 (IQR 1.3–1.7). In multivariable regression analyses examining the association between trial characteristics (medical specialty, inclusion of paediatric patients, mortality as a sole or part of a composite primary outcome, presence of industry funding) and non-inferiority margin size, only medical specialty was significantly associated with non-inferiority margin size. Conclusion: Absolute and relative non-inferiority margins used in published trials comparing medications are large, allowing conclusions of non-inferiority in the context of large differences in mortality. Accepting the potential for large increases in outcomes involving mortality while declaring non-inferiority is a challenging methodological issue in the conduct of non-inferiority trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Piaggio, G., Elbourne, D. R., Pocock, S. J., Evans, S. J. W., Altman, D. G., & CONSORT Group, F. T. (2012) · JAMA · doi:10.1001/jama.2012.87802 · Cited by 2,428
Reporting of Noninferiority and Equivalence Randomized Trials: An Extension of the CONSORT Statement
Piaggio, G., Elbourne, D. R., Altman, D. G., Pocock, S. J., Evans, S. J. W., & CONSORT Group, F. T. (2006) · JAMA · doi:10.1001/jama.295.10.1152 · Cited by 1,153
Schiller, P., Burchardi, N., Niestroj, M., & Kieser, M. (2012) · Trials · doi:10.1186/1745-6215-13-214 · Cited by 53
Cited by
Antibiotic treatment for 7 versus 14 days in patients with bloodstream infections
The BALANCE Investigators (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2404991 · Cited by 158
“13,14,22,23,30,31 This trial was underpowered to assess whether prolonged treatment conferred a potential benefit in some of the smaller subgroups of patients.”
O’Brien, B., Campbell, N. G., Allen, E., Jamal, Z., Sturgess, J., Sanders, J., Opondo, C., Roberts, N., Aron, J., Maccaroni, M. R., et al. (2024) · JAMA · doi:10.1001/jama.2024.17888 · Cited by 36
Lee, T. C., Prosty, C. J., Fralick, M., Huttner, A., McDonald, E. G., Molina, J., Paul, M., Pinto, R., Rishu, A., von Dach, E., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.1421 · Cited by 30
Self-citation
Metadata
- Authors
- Pong, S., Urner, M., Fowler, R. A., Mitsakakis, N., Seto, W., Hutchison, J. S., Science, M., & Daneman, N.
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2021-04
- Volume
- 11
- Issue
- 4
- Pages
- e044480
- ISSN
- 2044-6055 (ISSN-L)
- OpenAlex
- W3156132131
- Cited by
- 35
- References
- 3
- FWCI
- 0.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Testing for non-inferior mortality: a systematic review of non-inferiority margin sizes and trial characteristics. https://app.cochat.ai/papers/10.1136/bmjopen-2020-044480
- The paper
- Pong, S., Urner, M., Fowler, R. A., Mitsakakis, N., Seto, W., Hutchison, J. S., Science, M., & Daneman, N. (2021). Testing for non-inferior mortality: a systematic review of non-inferiority margin sizes and trial characteristics. BMJ Open. https://doi.org/10.1136/bmjopen-2020-044480
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.